Medicine Supply Notification: Admelog® (insulin lispro)
The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following product:
- Admelog® (insulin lispro) 100units/ml solution for injection 3ml cartridges
- Admelog® (insulin lispro) 100units/ml solution for injection 3ml pre-filled pens
- Admelog® (insulin lispro) 100units/ml solution for injection 10ml vials
MSN/2025/052
Tier 2 – medium impact
Date of issue: 18/09/2025
- Admelog® (insulin lispro) 100 units/ml solution for injection cartridges, pre-filled pens and vials are being discontinued with supplies anticipated to be exhausted by mid-March 2026, late March 2026 and mid-June 2026, respectively
- Humalog® (insulin lispro) 100units/ml solution for injection cartridges, KwikPens® and vials remain available and can support increased demand.
A copy of this medicine supply notification, including actions required and supporting information, has been sent to all pharmacy NHS email addresses.
DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.
The Tool also details any changes to resupply dates and updates to the entries.
To access the Tool, you will need an NHS email address. Once set up and logged in, you will be able to access it online.
New shortages not listed on the SPS website can be reported using our shortage reporting tool.
